Heart Disease News and Research

Latest Heart Disease News and Research

TRYTON-LM clinical study enrolls first two patients

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the enrollment of the first two patients in TRYTON-LM, a prospective, single-arm study evaluating the feasibility of the Tryton stent in conjunction with Abbott’s XIENCE PRIME Everolimus Eluting Coronary Stent System to treat stable patients with complex de novo bifurcation lesions involving the left main coronary artery.

9 Dec 2009

BIOLASE Technology's Waterlase MD laser system receives FDA marketing clearance

BIOLASE Technology, Inc., the world's leading dental laser company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Waterlase MD™ laser system for removal of subgingival calculi to prevent and treat periodontitis, the greatest cause of tooth loss for adults over 35 and a condition impacting more than half of Americans over the age of 55, as reported by the American Academy of Periodontology (AAP).

9 Dec 2009

Manuscript on KBR method to be published in American Journal of Cardiology

VentriPoint Diagnostics Ltd. ("VentriPoint" or the "Corporation") is pleased to announce that the manuscript entitled, "Accuracy of Knowledge Based Reconstruction (KBR) for Measurement of Right Ventricular Volume and Function in Patients with Tetralogy of Fallot" has been accepted for publication in the American Journal of Cardiology.

9 Dec 2009

VERTICAL Phase II trial results for NHL released

The Takeda Oncology Company today reported data from a clinical trial evaluating a VELCADE based combination for patients with relapsed/refractory non-Hodgkin’s lymphoma (NHL).

9 Dec 2009

Insurrecta Nex: Will Catholic Bishops truly defend babies?

Beginning Wednesday, December 9, Insurrecta Nex team members will travel to 13 Cathedrals in 9 states to hold vigils and press conferences. The tour will finish at the Boston Cathedral, the seat of Cardinal O'Malley, the site of decades of scandal with the Kennedy and the Kerry families.

9 Dec 2009

New Acesis software platform improves patient safety and quality care

Acesis, the enterprise software company focused on healthcare performance improvement, today announced results from its first six months of service for the University of California, San Francisco (UCSF) Division of Hospital Medicine.

9 Dec 2009

Experts call on Europe's policy makers to take urgent action against preventable strokes

A report launched today by experts from medical and patient communities calls on Europe's policy makers to take urgent action against preventable strokes that strike thousands of atrial fibrillation (AF) patients each year

9 Dec 2009

MEP HG and heart experts discuss EU achievements in combating cardiovascular disease

Members of the European Parliament Heart Group (MEP HG) meet today (9 December), in Brussels, with the Cardiology profession and representatives of national Heart Foundations to evaluate the achievements at EU level in combating Cardiovascular Disease (CVD), and to reveal the need for further action.

9 Dec 2009

Researchers describe how PDNF protein prolongs the life of T. cruzi parasite

The parasite Trypanosoma cruzi (or T. cruzi), which causes Chagas' disease, will go to great lengths to evade death once it has infected human host cells, researchers have discovered. In a study published in the November 17 online issue of Science Signaling, the researchers describe how a protein called parasite-derived neurotrophic factor (PDNF) prolongs the life of the T. cruzi parasite by activating anti-apoptotic (or anti-cell-death) molecules in the host cell. These protective mechanisms help to explain how host cells continue to survive despite being exploited by T. cruzi parasites.

9 Dec 2009

People living in deprived neighborhoods more likely to die from cancer and heart disease

Regardless of an individual's dietary and lifestyle risk factors, living in a poorer or more socioeconomically deprived neighborhood may increase a person's risk for death, according to data presented at the American Association for Cancer Research Conference on Frontiers in Cancer Prevention Research, held Dec. 6-9, 2009.

9 Dec 2009

New regenerative therapies for heart disease being developed

Bioengineers from University of California, San Diego are developing new regenerative therapies for heart disease. The work could influence the way in which regenerative therapies for cardiovascular and other diseases are treated in the future.

9 Dec 2009

Research suggests that everyday germs may prevent diseases in adulthood

A new Northwestern University study suggests that American parents should ease up on antibacterial soap and perhaps allow their little ones a romp or two in the mud --- or at least a much better acquaintance with everyday germs.

9 Dec 2009

New guidelines on the management of antithrombotic agents for endoscopic procedures published

According to a new guideline from the American Society for Gastrointestinal Endoscopy (ASGE) regarding the management of antithrombotic agents for endoscopy, aspirin and/or NSAIDs may be continued for all elective endoscopic procedures.

9 Dec 2009

TGen and Scottsdale Healthcare test PHA-848125ac drug for thymic cancer

The Translational Genomics Research Institute (TGen) and Scottsdale Healthcare are testing a new drug specifically for thymic cancer based on early promising results at Scottsdale Healthcare.

9 Dec 2009

On-X Life Technologies, Cleveland Clinic enter into an exclusive worldwide license agreement

Austin-based On-X® Life Technologies, Inc., manufacturers of the On-X® Prosthetic Heart Valve, announced today that it has entered into an exclusive worldwide license with the Cleveland Clinic for a system of products intended to improve and simplify the replacement of damaged or severed mitral valve chordae.

9 Dec 2009

Comprehensive report details the prevalence, implications, costs of caregiving and demographics of caregivers

Caregiving is still mostly a woman's job and many women are putting their career and financial futures on hold as they juggle part-time caregiving and full-time job requirements.

9 Dec 2009

Doctors around the world join the battle against human trafficking

Doctors At War, a newly formed 501(c)3 organization, is putting out a call-to-action for doctors worldwide to join them in the fight against the global sex trade. The long-term healthcare ramifications of the estimated 27 million victims throughout the world include post-traumatic stress disorder (PTSD), panic attacks, depression, and a host of other mental health issues along with countless physical health problems including HIV, STD's, malnutrition, sterility, and the effects of repeated physical trauma.

9 Dec 2009